Wall Street analysts expect Colgate-Palmolive (NYSE:CL) to announce earnings per share of $0.75 for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Colgate-Palmolive’s earnings. The highest EPS estimate is $0.76 and the lowest is $0.74. Colgate-Palmolive also posted earnings per share of $0.75 during the same quarter last year. The business is scheduled to report its next quarterly earnings report on Friday, January 26th.

On average, analysts expect that Colgate-Palmolive will report full-year earnings of $2.88 per share for the current year, with EPS estimates ranging from $2.86 to $2.95. For the next financial year, analysts anticipate that the company will report earnings of $3.08 per share, with EPS estimates ranging from $3.01 to $3.15. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that that provide coverage for Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same period in the previous year, the business earned $0.73 EPS. The firm’s revenue for the quarter was up 2.8% on a year-over-year basis.

Several brokerages recently weighed in on CL. SunTrust Banks upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and boosted their target price for the stock from $65.00 to $85.00 in a research note on Wednesday, October 11th. Societe Generale downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price on the stock. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Citigroup dropped their target price on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research note on Thursday, November 2nd. Stifel Nicolaus set a $73.00 target price on Colgate-Palmolive and gave the stock a “hold” rating in a research note on Sunday, October 29th. Finally, Royal Bank of Canada restated a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have issued a buy rating to the company’s stock. Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $76.04.

In other news, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the sale, the chief marketing officer now owns 45,217 shares in the company, valued at $3,313,501.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Victoria L. Dolan sold 10,000 shares of the company’s stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $73.07, for a total value of $730,700.00. Following the completion of the sale, the insider now owns 60,528 shares in the company, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. In the last quarter, insiders have sold 181,048 shares of company stock worth $13,168,995. Company insiders own 1.02% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in shares of Colgate-Palmolive by 2.4% in the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after buying an additional 1,621,392 shares during the last quarter. Renaissance Technologies LLC boosted its stake in shares of Colgate-Palmolive by 42.4% in the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after buying an additional 2,903,800 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of Colgate-Palmolive by 25.3% in the second quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock worth $508,111,000 after buying an additional 1,385,946 shares during the last quarter. First Eagle Investment Management LLC boosted its stake in shares of Colgate-Palmolive by 35.8% in the third quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after buying an additional 1,750,417 shares during the last quarter. Finally, Harding Loevner LP boosted its stake in shares of Colgate-Palmolive by 92.0% in the third quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock worth $176,329,000 after buying an additional 2,272,675 shares during the last quarter. Hedge funds and other institutional investors own 72.96% of the company’s stock.

Shares of Colgate-Palmolive (NYSE:CL) traded up $0.81 during mid-day trading on Friday, reaching $74.05. The company had a trading volume of 4,227,379 shares, compared to its average volume of 3,141,084. Colgate-Palmolive has a 1 year low of $63.43 and a 1 year high of $77.27. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. The stock has a market cap of $65,023.68, a P/E ratio of 25.80, a price-to-earnings-growth ratio of 3.39 and a beta of 0.81.

TRADEMARK VIOLATION WARNING: “Colgate-Palmolive (CL) Expected to Announce Earnings of $0.75 Per Share” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.watchlistnews.com/colgate-palmolive-cl-expected-to-announce-earnings-of-0-75-per-share/1770203.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.